{"organizations": [], "uuid": "2d2356bb9e69a11ccee40511fd5204b7bd57862f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-wave-life-sciences-reports-qtrly-l/brief-wave-life-sciences-reports-qtrly-loss-per-share-1-26-idUSASC0A0YW", "country": "US", "domain_rank": 408, "title": "BRIEF-Wave Life Sciences Reports Qtrly Loss Per Share $1.26", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-09T15:45:00.000+03:00", "replies_count": 0, "uuid": "2d2356bb9e69a11ccee40511fd5204b7bd57862f"}, "author": "", "url": "https://www.reuters.com/article/brief-wave-life-sciences-reports-qtrly-l/brief-wave-life-sciences-reports-qtrly-loss-per-share-1-26-idUSASC0A0YW", "ord_in_thread": 0, "title": "BRIEF-Wave Life Sciences Reports Qtrly Loss Per Share $1.26", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-wave life sciences", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "wave life sciences ltd", "sentiment": "none"}, {"name": "takeda", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 9, 2018 / 12:47 PM / Updated 13 minutes ago BRIEF-Wave Life Sciences Reports Qtrly Loss Per Share $1.26 Reuters Staff\nMay 9 (Reuters) - WAVE Life Sciences Ltd:\n* WAVE LIFE SCIENCES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE * WAVE LIFE SCIENCES LTD QTRLY LOSS PER SHARE $1.26\n* WAVE LIFE SCIENCES LTD - ENDED Q1 OF 2018 WITH $110.5 MILLION IN CASH AND CASH EQUIVALENTS\n* WAVE LIFE SCIENCES - EXPECTS CASH, CASH EQUIVALENTS, $170.0 MILLION CASH FROM TAKEDA IN APRIL, ENABLE FUNDING OPERATING, CAPEX REQUIREMENTS TO 2020 END Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-05-09T15:45:00.000+03:00", "crawled": "2018-05-09T16:05:09.006+03:00", "highlightTitle": ""}